TMCITREACE MEDICAL CONCEPTS, INC.vs its industry peers
A metric-by-metric comparison of TREACE MEDICAL CONCEPTS, INC. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMCIThis | $280M#8 | — | 4.1x#9 | 1.3x#3 | 1.6%#10 | -5.8%#9 | -25.5%#8 | -87.1%#12 | -47.4%#9 | 2#11 | -34.7%#7 | — |
| SI | $407M#1 | 0.1x#1 | 3.3x#6 | 8.6x#14 | 49.6%#4 | -158.4%#14 | -55.6%#10 | -32.5%#9 | -22.9%#7 | 3#10 | 73.6%#2 | — |
| CARL | $402M#2 | 134.0x#7 | 4.8x#11 | 8.0x#12 | 85.9%#2 | -22.2%#11 | -60.5%#12 | -35.2%#10 | -57.3%#11 | 5#4 | 19.0%#6 | — |
| OFIX | $360M#3 | — | 0.8x#2 | 0.4x#2 | 2.9%#9 | 26.8%#6 | -9.9%#7 | -21.5%#7 | -14.9%#6 | 5#4 | -44.9%#8 | — |
| EMBC | $349M#4 | 4.2x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#7 | 22.4%#2 | — | 27.0%#1 | 6#3 | -49.5%#10 | 10.0%#1 |
| MOBI | $344M#5 | — | 2.0x#5 | — | — | — | — | 0.0%#5 | — | — | — | — |
| OBIO | $340M#6 | — | 3.4x#7 | 10.2x#15 | 1169.2%#1 | 13.6%#8 | -154.7%#15 | -52.8%#11 | -54.9%#10 | — | 51.1%#3 | 5.9%#2 |
| CLPT | $311M#7 | — | 11.4x#13 | 8.4x#13 | 17.8%#5 | -35.0%#13 | -65.4%#14 | -93.7%#13 | — | — | -49.0%#9 | — |
| CTSO | $258M#9 | — | — | 7.0x#11 | 4.1%#8 | 60.4%#4 | -39.8%#9 | — | -122.1%#12 | 4#8 | -72.5%#11 | — |
| ANIK | $257M#10 | — | 1.9x#4 | 2.3x#6 | -5.9%#13 | 80.4%#3 | -9.8%#6 | -8.0%#6 | -8.8%#5 | 4#8 | 95.1%#1 | — |
| INFU | $249M#11 | 31.3x#6 | 4.2x#10 | 1.7x#4 | 6.4%#7 | 182.6%#2 | 8.3%#5 | 11.2%#3 | 9.5%#4 | 9#1 | 20.9%#5 | — |
| OSUR | $248M#12 | — | 0.8x#1 | 2.2x#5 | -38.1%#15 | -252.5%#15 | -62.6%#13 | -21.6%#8 | -43.8%#8 | — | 35.2%#4 | — |
| IDXG | $240M#13 | 9.9x#3 | 10.3x#12 | 6.2x#10 | -17.5%#14 | 267.2%#1 | 10.5%#4 | 105.8%#1 | 14.2%#3 | 5#4 | — | — |
| UTMD | $226M#14 | 21.6x#5 | 1.8x#3 | 5.9x#9 | -5.8%#12 | -18.7%#10 | 29.6%#1 | 9.2%#4 | — | — | — | 1.8%#3 |
| TLSI | $218M#15 | — | 33.3x#14 | 4.8x#8 | 53.4%#3 | -30.6%#12 | -59.7%#11 | -598.9%#14 | — | 5#4 | — | — |
| PDEX | $194M#16 | 16.7x#4 | 3.9x#8 | 2.5x#7 | 16.5%#6 | 52.2%#5 | 16.8%#3 | 27.7%#2 | 17.9%#2 | 7#2 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice